SAN FRANCISCO, CA (October 4, 2013) – This study is a report of clinical and economic outcome data of a hospital-funded Indigent Healthcare Program conducted in 11 Infectious Disease (ID) Physician Office Infusion Centers (POICs) during 2012. The Indigent Healthcare...
SAN FRANCISCO, CA (October 4, 2013) – A multi-center retrospective review of 120 patients receiving intravenous antibiotics (IVAB) for complicated intra-abdominal infections (IAI) in a physician office infusion center (POIC) was conducted to determine the...
SAN FRANCISCO, CA (October 9, 2013) – A multi-center review of 100 patients receiving Vancomycin was conducted to determine the effectiveness of patient monitoring and the recognition of adverse events in an outpatient setting. Fifty-one of the patients were female...
SUGAR LAND, TX – Multidrug-resistant osteomyelitis was successfully treated with telavancin, rifampin, and meropenem, as published in an article in The Annals of Pharmacotherapy. Primary author was Mary Beth Brinkman, a research student at the time with Healix®, in...
SAN DIEGO, CA (October 19, 2012) – A retrospective review of 1,352 patients treated at nine Infectious Disease POICs with intravenous antibiotics (IVAB) from January 1 to June 30, 2011, was conducted to assess the reduced risk level of developing health care...
SAN DIEGO, CA (October 19, 2012) – A retrospective, multicenter review was conducted of eligible patients treated in the POIC from January 1- June 30, 2011, including 30-day follow-up to compare outcomes and costs in a POIC versus treatment after hospital discharge....
Recent Comments